Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameJBM Healthcare
Stock Code02161
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們為總部設於香港的領先品牌醫療保健品推廣及分銷公司,產品據點遍及大中華、東南亞及其他選定國家。產品組合包括消費者醫療保健品(品牌藥及健康保健品)及品牌中藥(非處方品牌中藥及濃縮中藥顆粒產品)。
Listing Date2021-02-05
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港九龍觀塘觀塘道388號創紀之城1期1座23樓2303-07室
Business Address (Hong Kong)香港九龍觀塘觀塘道388號創紀之城1期1座23樓2303-07室
Place of Incorporation中国
Listing Method全球发售 (公开发售 + 国际配售)
Listing BoardMain Board
Websitejbmhealthcare.com.hk
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 1.20 / shares
Offer Price RangeFinal offer price only, no range
Lot Size2,000 shares
Entry ThresholdHK$ 2,400
Par ValueRMB 1.0 / shares
Offer Period2026-06-05 to 2026-06-10
Global Offering Shares11,464,100 shares
HK Public Offer Shares (Initial)1,146,500 shares (10.0%)
Public Offer Lots (Initial)573lots (Pool A286lots,Pool B287lots)
International Placing Shares (Initial)10,317,600 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO893,686,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 13,756,920

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 2,000 HK$ 2,400
2 lots 4,000 HK$ 4,800
3 lots 6,000 HK$ 7,200
4 lots 8,000 HK$ 9,600
5 lots 10,000 HK$ 12,000
6 lots 12,000 HK$ 14,400
7 lots 14,000 HK$ 16,800
8 lots 16,000 HK$ 19,200
9 lots 18,000 HK$ 21,600
10 lots 20,000 HK$ 24,000
15 lots 30,000 HK$ 36,000
20 lots 40,000 HK$ 48,000
25 lots 50,000 HK$ 60,000
30 lots 60,000 HK$ 72,000
35 lots 70,000 HK$ 84,000
40 lots 80,000 HK$ 96,000
45 lots 90,000 HK$ 108,000
50 lots 100,000 HK$ 120,000
100 lots 200,000 HK$ 240,000
150 lots 300,000 HK$ 360,000
200 lots 400,000 HK$ 480,000
250 lots 500,000 HK$ 600,000
300 lots 600,000 HK$ 720,000
350 lots 700,000 HK$ 840,000
400 lots 800,000 HK$ 960,000
450 lots 900,000 HK$ 1,080,000
500 lots 1,000,000 HK$ 1,200,000
1,000 lots 2,000,000 HK$ 2,400,000
1,500 lots 3,000,000 HK$ 3,600,000
2,000 lots 4,000,000 HK$ 4,800,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
2,500 lots 5,000,000 HK$ 6,000,000
3,000 lots 6,000,000 HK$ 7,200,000
4,500 lots 9,000,000 HK$ 10,800,000
5,000 lots 10,000,000 HK$ 12,000,000
11,171 lots 22,342,000 HK$ 26,810,400

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 1.74B
Est. Threshold HK$ 9.44B
Analysis Result HK market cap below threshold, need +441%

Valuation & Financials

Market Cap (at Offer Price)HK$ 1,072,423,200
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約44.3百萬港元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 43,000,000
Listing Expenses / Funds Raised~312.57%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 2018-032019-03
Revenue 86,004100,747
Cost of sales -44,330-53,741
Gross profit 41,67447,006
Other income and gains, net 1338
Administrative expenses -16,927-20,761
Operating profit 24,76026,283
Net finance costs -43-117
Profit before tax 24,71726,166
Income tax expense -4,054-4,119
Profit for the year 20,66322,047
Balance Sheet
Item 2018-032019-03
Cash and cash equivalents 9,80623,155
Trade and bills receivables 8,8659,627
Inventories 16,42411,649
Total current assets 35,09544,431
Total current liabilities 16,62619,541
Total equity 20,66328,027
Cash Flow Statement
Item 2018-032019-032019-08
Net cash from operating activities 18,83230,859
Net cash from investing activities -484-312
Net cash from financing activities -18,275-17,198
Net increase in cash 7313,349
Depreciation of PP&E 17018660
Depreciation of right-of-use assets 6162,4311,744
Purchase of PP&E -486-318-11
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 2.16
First Day OpenHK$ 1.48
First Day Change80.00%
First Day Volume340448000.0
First Day Turnover756998000.0
Use of Proceeds
1、約47.2%或約5.0百萬港元為品牌中藥的產品組合開發及品牌管理提供資金; 2、約43.4%或約4.6百萬港元為自第三方品牌擁有人獲取額外分銷權的付款提供資金; 3、約9.4%或約1.0百萬港元補充我們的營運資金及用于一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
中国银河国际证券(香港)有限公司 CE AXM459
Joint Bookrunners (1)
中国银河国际证券(香港)有限公司 CE AXM459
Joint Lead Managers (8)
中国银河国际证券(香港)有限公司 CE AXM459 CINDA INTERNATIONAL CAPITAL LIMITED CE AEE541 Eddid Securities and Futures Limited CE BHT550 Fosun International Securities Limited CE AAF432 SILVER NILE GLOBAL INVESTMENTS LIMITED CE BJB477 迈时资本有限公司 CE BNO600 SOUTHWEST SECURITIES (HK) BROKERAGE LIMITED CE ACB501 TUS Corporate Finance Limited CE BJL235

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman岑廣業—
Company Secretary歐敏兒—
No director data available.

Major Shareholders

Major Shareholders & Holdings緊隨分拆完成後,控股股東JBM Group BVI持有約53.74%股權;最終控股股東岑先生控制約69.67%權益;Lincoln’s Hill持有約11.90%。
About this page

This page shows JBM Healthcare (02161) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect